icrf 193 has been researched along with merbarone in 1 studies
| Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (merbarone) | Trials (merbarone) | Recent Studies (post-2010) (merbarone) |
|---|---|---|---|---|---|
| 155 | 0 | 30 | 74 | 11 | 16 |
| Protein | Taxonomy | icrf 193 (IC50) | merbarone (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 12 | Homo sapiens (human) | 5.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikhailov, A; Rieder, CL; Shinohara, M | 1 |
1 other study(ies) available for icrf 193 and merbarone
| Article | Year |
|---|---|
Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway.
Topics: Aclarubicin; Anaphase; Antibiotics, Antineoplastic; Antineoplastic Agents; Blotting, Western; Catalysis; Cell Line, Tumor; Chromatin; Chromosomes; Diketopiperazines; DNA Damage; Doxorubicin; Enzyme Activation; G2 Phase; HeLa Cells; Histone Deacetylase Inhibitors; Histones; Humans; Immunohistochemistry; Lasers; Microscopy, Video; Mitogen-Activated Protein Kinases; Mitosis; Osmosis; p38 Mitogen-Activated Protein Kinases; Piperazines; Spindle Apparatus; Thiobarbiturates; Time Factors; Topoisomerase II Inhibitors | 2004 |